Reissuing release to remove “million” after “$5,100,000” in the headline and first sentence of the text. The updated release reads: BONE BIOLOGICS PRICES $5,100,000 UNDERWRITTEN PUBLIC OFFERINGBone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces the pricing of an underwritten public offering of 3,777,778 units of securities at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000, before deducting underwriting discounts and commissions and other estimated offering expenses. Each unit consists of: (i) one share of common stock; (ii) one Series A warrant to purchase one share of common stock at an exercise pr(…) Read More »